caretrace.iopowered by▸healthparse
SearchCohort Builder
Tools▾
KOL FinderTerritoriesDrug Compare
AI Query
Browse▾
By stateBy specialty
Pricing
SearchCohort BuilderToolsKOL FinderTerritoriesDrug CompareAI QueryBrowseBy stateBy specialtyPricing
PROVIDER PROFILE · NPI 1447300322

Nirav VakhariaM.D.

Internal MedicineCleveland, OHI
CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore
OIG/SAM exclusion screening, sanctions history
© 2026 CareTrace
PricingContactPrivacyTerms
REFERRAL NETWORK

Where Nirav Vakharia's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 4 inbound referrers · 5 outbound destinations.

Receives referrals from
Inbound — who sends patients here
PhysicianPatientsVisits
Ruchi Yadav
Diagnostic Radiology · Cleveland, OH
1222
CLEVELAND CLINIC FOUNDATION CLEVELAND CLINIC HOME CARE1236
George Feyda
Internal Medicine · Cleveland, OH
1232
Mahesh Manne
Internal Medicine · Cleveland, OH
1170
Refers patients to
Outbound — where patients go next
PhysicianPatientsVisits
THE CLEVELAND CLINIC FOUNDATION2091,843
UNDERWOOD, DONALD1941
HACHAMOVITCH, RORY1852
Maan Fares
Cardiology · Parma, OH
1134
VANDYKE, CAROLYN1119
Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.
MEDICARE UTILIZATION · PART B · 2024
No data available for this provider in 2024.
PRESCRIBING · PART D · 2024
Total Rx claims
87
Beneficiaries
—
Total drug cost
$2K
Distinct drugs
7
Brand share
0.0%
Top prescribed drugs
Rosuvastatin Calcium14 claims
Losartan Potassium14 claims
Carvedilol13 claims
Duloxetine Hcl12 claims
Candesartan Cilexetil12 claims
QUALITY · MIPS · 2024
No data available for this provider in 2024.
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024
No data available for this provider in 2024.